Prevention of 90-day inpatient detoxification readmission for opioid use disorder by a community-based life-changing individualized medically assisted evidence-based treatment (C.L.I.M.B.) program: A quasi-experimental study

<h4>Background</h4> Evidence for community-based strategies to reduce inpatient detoxification readmission for opioid use disorder (OUD) is scant. A pilot program was designed to provide individualized structured treatment plans, including addressing prolonged withdrawal symptoms, family...

Full description

Bibliographic Details
Main Authors: Zhehui Luo, Canopy Roychoudhury, William S. Pompos, James DiMaria, Cynthia M. Robinette, Purva H. Gore, Rohon Roychoudhury, William Beecroft
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754176/?tool=EBI
_version_ 1811195593658204160
author Zhehui Luo
Canopy Roychoudhury
William S. Pompos
James DiMaria
Cynthia M. Robinette
Purva H. Gore
Rohon Roychoudhury
William Beecroft
author_facet Zhehui Luo
Canopy Roychoudhury
William S. Pompos
James DiMaria
Cynthia M. Robinette
Purva H. Gore
Rohon Roychoudhury
William Beecroft
author_sort Zhehui Luo
collection DOAJ
description <h4>Background</h4> Evidence for community-based strategies to reduce inpatient detoxification readmission for opioid use disorder (OUD) is scant. A pilot program was designed to provide individualized structured treatment plans, including addressing prolonged withdrawal symptoms, family/systems assessment, and contingency management, to reduce readmission after the index inpatient detoxification. <h4>Methods</h4> A non-randomized quasi-experimental design was used to compare the pilot facilities (treatment) and comparison facilities before and after the program started, i.e., a simple difference-in-differences (DID) strategy. Adults 18 years and older who met the Diagnostic and Statistical Manual of Mental Disorders version 5 criteria for OUD and had an inpatient detoxification admission at any OUD treatment facility in two study periods between 7/2016 and 3/2020 were included. Readmission for inpatient detoxification in 90-days after the index stay was the primary outcome, and partial hospitalization, intensive outpatient care, outpatient services, and medications for OUD were the secondary outcomes. Six statistical estimation methods were used to triangulate evidence and adjust for potential confounding factors between treatment and comparison groups. <h4>Results</h4> A total of 2,320 unique patients in the pilot and comparison facilities with 2,443 index inpatient detoxification admissions in the pre- and post-periods were included. Compared with patients in comparison facilities, patients in the C.L.I.M.B. facilities had higher readmission in the pre-period (unadjusted readmission 17.0% vs. 10.6%), but similar rates in the post-period (12.3% vs. 10.6%) after the implementation of the pilot program. For 90-day readmission, all DID estimates were not statistically significant (adjusted estimates ranged from 6 to 9 percentage points difference favoring the C.L.I.M.B. program). There was no significant improvement in the secondary outcomes of utilizations in lower level of care and medications for OUD in C.L.I.M.B. facilities. <h4>Conclusions</h4> We found a reduction in readmission in the pilot facilities between the two periods, but the results were not statistically significant compared with the comparison facilities and the utilization of lower level of care services remained low. Even though providers in the pilot OUD treatment facilities actively worked with health plans to standardize care for patients with OUD, more strategies are needed to improve treatment engagement and retention after an inpatient detoxification.
first_indexed 2024-04-12T00:45:48Z
format Article
id doaj.art-2acb8c3a16fc4ab7a65e1614740545c1
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T00:45:48Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-2acb8c3a16fc4ab7a65e1614740545c12022-12-22T03:54:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-011712Prevention of 90-day inpatient detoxification readmission for opioid use disorder by a community-based life-changing individualized medically assisted evidence-based treatment (C.L.I.M.B.) program: A quasi-experimental studyZhehui LuoCanopy RoychoudhuryWilliam S. PomposJames DiMariaCynthia M. RobinettePurva H. GoreRohon RoychoudhuryWilliam Beecroft<h4>Background</h4> Evidence for community-based strategies to reduce inpatient detoxification readmission for opioid use disorder (OUD) is scant. A pilot program was designed to provide individualized structured treatment plans, including addressing prolonged withdrawal symptoms, family/systems assessment, and contingency management, to reduce readmission after the index inpatient detoxification. <h4>Methods</h4> A non-randomized quasi-experimental design was used to compare the pilot facilities (treatment) and comparison facilities before and after the program started, i.e., a simple difference-in-differences (DID) strategy. Adults 18 years and older who met the Diagnostic and Statistical Manual of Mental Disorders version 5 criteria for OUD and had an inpatient detoxification admission at any OUD treatment facility in two study periods between 7/2016 and 3/2020 were included. Readmission for inpatient detoxification in 90-days after the index stay was the primary outcome, and partial hospitalization, intensive outpatient care, outpatient services, and medications for OUD were the secondary outcomes. Six statistical estimation methods were used to triangulate evidence and adjust for potential confounding factors between treatment and comparison groups. <h4>Results</h4> A total of 2,320 unique patients in the pilot and comparison facilities with 2,443 index inpatient detoxification admissions in the pre- and post-periods were included. Compared with patients in comparison facilities, patients in the C.L.I.M.B. facilities had higher readmission in the pre-period (unadjusted readmission 17.0% vs. 10.6%), but similar rates in the post-period (12.3% vs. 10.6%) after the implementation of the pilot program. For 90-day readmission, all DID estimates were not statistically significant (adjusted estimates ranged from 6 to 9 percentage points difference favoring the C.L.I.M.B. program). There was no significant improvement in the secondary outcomes of utilizations in lower level of care and medications for OUD in C.L.I.M.B. facilities. <h4>Conclusions</h4> We found a reduction in readmission in the pilot facilities between the two periods, but the results were not statistically significant compared with the comparison facilities and the utilization of lower level of care services remained low. Even though providers in the pilot OUD treatment facilities actively worked with health plans to standardize care for patients with OUD, more strategies are needed to improve treatment engagement and retention after an inpatient detoxification.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754176/?tool=EBI
spellingShingle Zhehui Luo
Canopy Roychoudhury
William S. Pompos
James DiMaria
Cynthia M. Robinette
Purva H. Gore
Rohon Roychoudhury
William Beecroft
Prevention of 90-day inpatient detoxification readmission for opioid use disorder by a community-based life-changing individualized medically assisted evidence-based treatment (C.L.I.M.B.) program: A quasi-experimental study
PLoS ONE
title Prevention of 90-day inpatient detoxification readmission for opioid use disorder by a community-based life-changing individualized medically assisted evidence-based treatment (C.L.I.M.B.) program: A quasi-experimental study
title_full Prevention of 90-day inpatient detoxification readmission for opioid use disorder by a community-based life-changing individualized medically assisted evidence-based treatment (C.L.I.M.B.) program: A quasi-experimental study
title_fullStr Prevention of 90-day inpatient detoxification readmission for opioid use disorder by a community-based life-changing individualized medically assisted evidence-based treatment (C.L.I.M.B.) program: A quasi-experimental study
title_full_unstemmed Prevention of 90-day inpatient detoxification readmission for opioid use disorder by a community-based life-changing individualized medically assisted evidence-based treatment (C.L.I.M.B.) program: A quasi-experimental study
title_short Prevention of 90-day inpatient detoxification readmission for opioid use disorder by a community-based life-changing individualized medically assisted evidence-based treatment (C.L.I.M.B.) program: A quasi-experimental study
title_sort prevention of 90 day inpatient detoxification readmission for opioid use disorder by a community based life changing individualized medically assisted evidence based treatment c l i m b program a quasi experimental study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754176/?tool=EBI
work_keys_str_mv AT zhehuiluo preventionof90dayinpatientdetoxificationreadmissionforopioidusedisorderbyacommunitybasedlifechangingindividualizedmedicallyassistedevidencebasedtreatmentclimbprogramaquasiexperimentalstudy
AT canopyroychoudhury preventionof90dayinpatientdetoxificationreadmissionforopioidusedisorderbyacommunitybasedlifechangingindividualizedmedicallyassistedevidencebasedtreatmentclimbprogramaquasiexperimentalstudy
AT williamspompos preventionof90dayinpatientdetoxificationreadmissionforopioidusedisorderbyacommunitybasedlifechangingindividualizedmedicallyassistedevidencebasedtreatmentclimbprogramaquasiexperimentalstudy
AT jamesdimaria preventionof90dayinpatientdetoxificationreadmissionforopioidusedisorderbyacommunitybasedlifechangingindividualizedmedicallyassistedevidencebasedtreatmentclimbprogramaquasiexperimentalstudy
AT cynthiamrobinette preventionof90dayinpatientdetoxificationreadmissionforopioidusedisorderbyacommunitybasedlifechangingindividualizedmedicallyassistedevidencebasedtreatmentclimbprogramaquasiexperimentalstudy
AT purvahgore preventionof90dayinpatientdetoxificationreadmissionforopioidusedisorderbyacommunitybasedlifechangingindividualizedmedicallyassistedevidencebasedtreatmentclimbprogramaquasiexperimentalstudy
AT rohonroychoudhury preventionof90dayinpatientdetoxificationreadmissionforopioidusedisorderbyacommunitybasedlifechangingindividualizedmedicallyassistedevidencebasedtreatmentclimbprogramaquasiexperimentalstudy
AT williambeecroft preventionof90dayinpatientdetoxificationreadmissionforopioidusedisorderbyacommunitybasedlifechangingindividualizedmedicallyassistedevidencebasedtreatmentclimbprogramaquasiexperimentalstudy